C-XON TZ 281.25

C-XON TZ 281.25

Powerful Dual-Action Antibiotic for Faster Infection Control
C-XON TZ 281.25 Injection is a broad-spectrum antibiotic injection formulated with Ceftriaxone 250mg and Tazobactam 31.25mg. This advanced antibacterial combination is designed to treat a wide range of bacterial infections by preventing bacterial growth and improving antibiotic effectiveness against resistant strains. Manufactured by Citric Labs, this injection is trusted for quality, safety, and effective infection management.

Ceftriaxone is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, while Tazobactam acts as a beta-lactamase inhibitor that helps overcome bacterial resistance and enhances the action of Ceftriaxone.

Composition

  • Ceftriaxone 250mg
  • Tazobactam 31.25mg
  • Dosage Form: Injection
SKU: 1311542d90ee Category:

Key Benefits

  • Broad-spectrum antibacterial action
  • Effective against resistant bacterial strains
  • Helps in faster recovery from infections
  • Suitable for hospital and clinical use
  • Enhanced antibiotic protection with Tazobactam
  • High-quality formulation from Citric Labs

Product Description

C-XON TZ 281.25 Injection contains Ceftriaxone 250mg and Tazobactam 31.25mg, a powerful antibiotic combination used for treating bacterial infections effectively. Offered by Citric Labs for quality-focused PCD Pharma Franchise business opportunities.

Related products

Why Choose Citric Labs for PCD Pharma Franchise?

  • High-quality WHO-GMP certified products
  • Monopoly-based PCD Pharma Franchise opportunities
  • Strong product portfolio including pain management range
  • Competitive pricing & high margins
  • Reliable supply chain across India